Analysts expect that OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) will announce earnings of ($0.11) per share for the current fiscal quarter, Zacks Investment Research reports. Zero analysts have provided estimates for OncoSec Medical’s earnings. OncoSec Medical reported earnings per share of ($0.25) during the same quarter last year, which indicates a positive year over […]
StockNews.com initiated coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a report released on Monday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, BTIG Research reduced their target price on OncoSec Medical from $10.00 to $5.00 and set a “buy” rating on the stock in a report on […]
StockNews.com initiated coverage on shares of OncoSec Medical (NASDAQ:ONCS – Get Rating) in a research report released on Sunday. The firm issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research lowered their target price on shares of OncoSec Medical from $10.00 to $5.00 and set a buy rating on the stock in […]
OncoSec Medical (NASDAQ:ONCS – Get Rating) had its target price cut by BTIG Research from $10.00 to $5.00 in a research note released on Wednesday morning, The Fly reports. They currently have a buy rating on the biotechnology company’s stock. Separately, StockNews.com assumed coverage on OncoSec Medical in a research note on Thursday, March 10th. […]
Wall Street analysts expect that OncoSec Medical Incorporated (NASDAQ:ONCS – Get Rating) will announce ($0.11) earnings per share for the current fiscal quarter, Zacks reports. Zero analysts have issued estimates for OncoSec Medical’s earnings. OncoSec Medical reported earnings per share of ($0.37) during the same quarter last year, which would indicate a positive year over […]